Everything’s up to Date in Kansas City, at Least When It Comes to Genomics The Genomic Medicine Center at Children’s Mercy Hospital is working to sequence 100,000 genomes of children, siblings, and their parents with the hope of producing the largest data set of genetic information about children with rare
Umbilical Cord Stem Cells Implanted Into COVID Patients Improve Survival Chances, Study Suggests An experimental treatment involving stem cells from umbilical cords could significantly reduce deaths and quicken recovery time for patients suffering the most severe form of Covid-19, a study suggests. Read more...
Common Brain Malformation Traced to Its Genetic Roots About one in 100 children has a common brain disorder called Chiari 1 malformation, but most of the time such children grow up normally and no one suspects a problem. But in about one in 10 of those children, the condition causes
Novel Form of Alzheimer’s Protein Found in Spinal Fluid Indicates Stage of the Disease A novel form of an Alzheimer’s protein found in the fluid that surrounds the brain and spinal cord indicates what stage of the disease a person is in, and tracks with tangles of tau protein in
A 73-Year-Old-Woman Who Should Have Gotten Alzheimer’s, Didn’t—Revitalizing a Search for the Cure Dr. Eric Reiman can't reveal the identity of the 73-year-old woman from a rugged mountain town outside Medellin, Colombia, who arrived at Boston's Logan Airport a couple of years ago for tests at Harvard Medical School. But
CIRM funded trial for sickle cell disease gives patient a chance for a better future For Evie Junior, personal health and fitness have always been a top priority. During his childhood, he was active and played football, basketball, and baseball in the Bronx, New York. One would never guess that
Bayer Accelerates Cell and Gene Therapy Drive with Atara Deal Bayer AG has struck a deal with Atara Biotherapeutics to jointly work on Atara’s CAR-T cell anti-tumour treatments, as the German group firms up its commitment to build a specialist cell and gene therapy development platform. Read more...
Aubagio Slows Grey Matter, Whole Brain Atrophy in CIS, Study Finds Studied for the first time, Aubagio (teriflunomide) slowed the loss of cortical grey matter and whole-brain volume in people with clinically isolated syndrome (CIS) during two years of therapy, a study found. The treatment was especially effective in those
Personalizing Recovery From ‘Lost’ Limbs MU researcher awarded $1.5 million grant from Department of Defense to gather real-life data on limb function. Read more...
Grant Helps Black Churches Fight COVID-19 COVID-19 has infected, hospitalized and killed Black Americans at a higher rate compared to whites. As it has with other racial health disparities, the University of Missouri-Kansas City is partnering with Black churches in Kansas City to fight this one. The National Institutes of